{"gene":"SLC12A6","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":1999,"finding":"KCC3 functions as a K+-Cl- cotransporter: expression in Xenopus laevis oocytes demonstrated Cl--dependent uptake of 86Rb+ that is strongly activated by cell swelling and weakly sensitive to furosemide. KCC3 has greater volume sensitivity than KCC1.","method":"Heterologous expression in Xenopus laevis oocytes, 86Rb+ flux assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro functional reconstitution in oocytes with ion flux assay, replicated by multiple independent groups","pmids":["10347194"],"is_preprint":false},{"year":1999,"finding":"KCC3 protein has 12 predicted transmembrane domains, a large extracellular loop between TM5 and TM6, and large NH2- and COOH-terminal cytoplasmic domains. It is activated by cell swelling, N-ethylmaleimide treatment, and staurosporine when transiently expressed in HEK-293 cells.","method":"Hydropathy analysis, transient transfection in HEK-293 cells, ion transport assay","journal":"The American journal of physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — functional characterization in mammalian cells with multiple activating conditions, independently confirmed","pmids":["10600773"],"is_preprint":false},{"year":2002,"finding":"A truncating frameshift mutation in KCC3 (2436delG, Thr813fsX813) causing ACCPN produces a protein that is correctly glycosylated and expressed at the plasma membrane but is non-functional as a K+-Cl- cotransporter.","method":"Heterologous expression of wild-type and mutant KCC3 in Xenopus laevis oocytes, ion flux assay, glycosylation analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution of mutant vs. wild-type in oocytes with flux assay plus biochemical characterization, disease-linked mutation","pmids":["12368912"],"is_preprint":false},{"year":2002,"finding":"Mice with targeted deletion of Slc12a6 (KCC3 knockout) develop locomotor deficit, peripheral neuropathy, and sensorimotor gating deficit, demonstrating a critical role for KCC3 in development and maintenance of the nervous system.","method":"Targeted gene deletion in mice, behavioral and electrophysiological phenotyping","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout mouse with defined neurological phenotype, replicated by independent groups","pmids":["12368912"],"is_preprint":false},{"year":2003,"finding":"KCC3 knockout mice show severely impaired cell volume regulation in renal tubules and neurons, moderately raised intraneuronal Cl- concentration, progressive neurodegeneration of peripheral and central nervous system, reduced seizure threshold, arterial hypertension, and slowly progressive deafness with degeneration of inner ear K+ recycling pathway cells.","method":"Targeted gene disruption in mice, cell volume measurements, electrocorticogram, blood pressure measurement, morphological analysis of inner ear","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — independent KCC3 knockout mouse line with multiple orthogonal functional readouts, replicates findings from PMID:12368912","pmids":["14532115"],"is_preprint":false},{"year":2001,"finding":"KCC3 is localized to myelin sheaths in spinal cord white matter tracts, pyramidal neurons, Purkinje cells, and the base of choroid plexus epithelium in mouse CNS. Two distinct protein isoforms (150 kDa in kidney, 170 kDa in brain) exist even after deglycosylation, corresponding to KCC3a (brain-predominant) and KCC3b (kidney-predominant) isoforms generated by alternative first coding exons.","method":"Western blot with KCC3-specific polyclonal antibody, Northern blot, immunofluorescence microscopy of mouse brain sections","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with antibody validation and Northern blot, single lab","pmids":["11246162"],"is_preprint":false},{"year":2001,"finding":"KCC3 expression and activity are regulated by tyrosine phosphorylation, and KCC3 promotes cell proliferation and cell cycle progression; IGF-1 upregulates KCC3 expression and stimulates growth, while TNF-alpha downregulates KCC3 and causes growth arrest.","method":"NIH/3T3 fibroblast expression system, DIOA inhibition, FACS cell cycle analysis, Western blot for Rb and cdc2 phosphorylation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (transport assay, FACS, Western blot) in single lab","pmids":["11724933"],"is_preprint":false},{"year":2005,"finding":"KCC3 has at least five NH2-terminal isoforms (KCC3a, KCC3b, KCC3a-x2M, KCC3b-x2M, KCC3a-S) generated by alternative promoter usage and splicing. All are activated by cell swelling but not under isotonic conditions. KCC3a kinetics: Km for Rb+ ~10.7 mM, Cl- ~7.3 mM; anion selectivity Br- > Cl- > PO4 = I- = SCN- = gluconate. KCC3b predominates in kidney proximal tubule at basolateral membrane.","method":"Northern blot, Western blot, immunofluorescence of mouse/rat kidney, functional expression in Xenopus laevis oocytes with 86Rb+ flux assay","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with kinetic characterization, direct localization, molecular characterization of isoforms, single lab with multiple orthogonal methods","pmids":["16048901"],"is_preprint":false},{"year":2006,"finding":"Hypertension in KCC3 knockout mice is neurogenic in origin: intracellular Cl- is elevated in vascular smooth muscle cells, but isolated arteries show no intrinsic vascular defect. Alpha1-adrenergic blockade or ganglionic transmission inhibition abolishes the blood pressure difference, and urinary catecholamines are elevated, demonstrating that elevated sympathetic tone mediates the hypertension.","method":"Vascular smooth muscle cell Cl- measurements, ex vivo vascular reactivity assays, in vivo pharmacological blockade, urinary catecholamine measurement in KCC3 knockout mice","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal experimental approaches (intracellular Cl- measurement, ex vivo, in vivo pharmacology, biomarkers) in single KCC3 knockout model","pmids":["16424367"],"is_preprint":false},{"year":2007,"finding":"KCC3 is expressed in sciatic nerve during early postnatal development (juvenile but not adult wild-type mice). Loss of KCC3 causes initial axonal swelling at P3 (before myelin abnormalities), followed by periaxonal fluid accumulation, and ultimately axon and myelin degeneration in adults with reduced nerve conduction velocity, implicating cell volume regulation in peripheral nerve maintenance.","method":"KCC3 knockout mouse analysis, morphometric analysis of sciatic nerves at multiple postnatal timepoints, nerve conduction velocity measurement, immunohistochemistry","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — systematic morphometric analysis with temporal resolution in KCC3 KO mice, multiple readouts","pmids":["17659877"],"is_preprint":false},{"year":2007,"finding":"IGF-1 upregulates KCC3 expression through PI3K and MAPK signaling cascades at the transcriptional level (blocked by actinomycin D), and KCC3-dependent transport is required for IGF-1-stimulated breast cancer cell proliferation.","method":"siRNA knockdown, KCC3 overexpression, pharmacological pathway inhibition, actinomycin D transcription block, xenograft tumor assay in SCID mice","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (siRNA, OE, pharmacological inhibition, in vivo xenograft) in single lab","pmids":["17133354"],"is_preprint":false},{"year":2012,"finding":"Neuronal-specific KCC3 expression is crucial for axon volume control and accounts for the neuropathic features of HMSN/ACC, while loss of non-neuronal KCC3 causes auditory impairment. KCC3 also plays an essential role in inflammatory pain pathways.","method":"Conditional Cre/LoxP transgenic mice (neuron-specific and ubiquitous truncated KCC3 expression), behavioral, electrophysiological, and histological phenotyping","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific knockout with multiple phenotypic readouts, dissects neuronal vs. non-neuronal contribution","pmids":["22423107"],"is_preprint":false},{"year":2012,"finding":"KCC3 contributes to Cl- extrusion in a subset of adult dorsal root ganglion sensory neurons, as demonstrated by gramicidin-perforated patch clamp in KCC3-/- mice showing failure of Cl- extrusion.","method":"Gramicidin-perforated patch-clamp recordings, quantitative RT-PCR, pharmacological inhibition with KCC cotransporter inhibitors in wild-type and KCC3-/- DRG neurons","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct electrophysiological measurement of Cl- in KCC3 knockout neurons with pharmacological controls","pmids":["22609694"],"is_preprint":false},{"year":2013,"finding":"A glutamic acid residue (E289) is essential for proper trafficking and function of KCC3: the E289G mutation causes glycosylation deficiency, ER/early Golgi retention, and failure to reach the plasma membrane. This mutant KCC3 forms heterodimers with KCC2 (shown by co-immunoprecipitation) and exerts dominant-negative effects by preventing proper trafficking of co-expressed wild-type KCC cotransporters.","method":"Co-immunoprecipitation, glycosylation analysis, confocal microscopy of subcellular localization, functional assay in Xenopus oocytes","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP for heterodimer formation, biochemical trafficking analysis, functional oocyte assay, multiple orthogonal methods in single lab","pmids":["23593405"],"is_preprint":false},{"year":2013,"finding":"SPAK complexed with its regulatory MO25 subunit phosphorylates KCC3 at Ser-96 in vitro. In Xenopus oocytes, Ser-96 is phosphorylated under isotonic conditions and dephosphorylated during hypotonic conditions, contributing to full activation. WNK3 promotes phosphorylation of Ser-96 as well as Thr-991 and Thr-1048. The triple mutant KCC3-S96A/T991A/T1048A has constitutive activity not further increased by hypotonicity or inhibited by WNK3.","method":"In vitro kinase assay with SPAK/MO25, site-directed mutagenesis, functional expression in Xenopus oocytes, HEK293 cells stably expressing WNK3","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay identifies phosphorylation site, mutagenesis confirms functional role, oocyte and cell line validation","pmids":["24043619"],"is_preprint":false},{"year":2014,"finding":"Loss of KCC3 specifically in parvalbumin-positive neurons leads to significant locomotor deficit in mice, identifying this cell population as critical for the pathogenic development of ACCPN. Loss of KCC3 in nociceptive neurons (Nav1.8-Cre) or Schwann cells (desert hedgehog-Cre) did not produce the locomotor phenotype.","method":"Tissue-specific KCC3 knockout mouse lines using Cre/loxP system (parvalbumin-Cre, NSE-Cre, Nav1.8-Cre, dhh-Cre), locomotor behavioral testing","journal":"Behavioural brain research","confidence":"High","confidence_rationale":"Tier 2 / Strong — four different cell-type-specific knockout lines tested, positive and negative results establish cell-type specificity","pmids":["25116249"],"is_preprint":false},{"year":2014,"finding":"KCC3 overexpression activates NF-κB and SPAK signaling, leading to p38 MAPK activation and MMP2 upregulation; SPAK is required for KCC3-mediated tumor cell invasiveness. NF-κB binds to the SPAK promoter in KCC3-overexpressing cells.","method":"siRNA knockdown, RT-PCR, NF-κB luciferase reporter assay, chromatin immunoprecipitation, gelatin zymography, mouse xenograft assay","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (ChIP, luciferase, gelatin zymography, in vivo xenograft) in single lab establishing pathway placement","pmids":["24655550"],"is_preprint":false},{"year":2015,"finding":"Phosphorylation of Thr-991 and Thr-1048 in the KCC3a C-terminus constitutes a potent molecular switch: alanine substitution at both sites (T991A/T1048A) activates KCC3a up to 25-fold under normally inhibitory isotonic conditions and is accompanied by reversal of NKCC1 activity, causing rapid and substantial reduction in intracellular K+ content via both Cl-dependent and Cl-independent (VRAC-sensitive) pathways.","method":"Site-directed mutagenesis (T991A/T1048A), ion transport assay, intracellular K+ measurement, pharmacological inhibition (DCPIB for VRAC, bumetanide for NKCC1)","journal":"Frontiers in cellular neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional assay and pharmacological dissection of pathways, multiple orthogonal readouts","pmids":["26217182"],"is_preprint":false},{"year":2016,"finding":"A de novo T991A mutation in KCC3 abolishes WNK kinase-dependent phosphorylation at Thr-991, resulting in constitutive KCC3 activity and compromised cell volume homeostasis. KCC3-T991A/T1048A knock-in mice exhibit constitutive KCC3 activity and recapitulate clinical features of the patient's progressive motor peripheral neuropathy, demonstrating that over-activation of KCC3 causes neurodegeneration.","method":"Exome sequencing (patient identification), cell volume assay in patient cells, KCC3-T991A/T1048A knock-in mouse generation, electrophysiological and histopathological analysis","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Strong — human mutation identified and functionally validated in patient cells and knock-in mouse model with multiple phenotypic readouts","pmids":["27485015"],"is_preprint":false},{"year":2019,"finding":"Spleen tyrosine kinase (SYK) phosphorylates a specific N-terminal tyrosine residue of KCC3, and this phosphorylation decreases KCC3 abundance at the plasma membrane. SYK depletion or inhibition increases KCC3 membrane surface levels (opposite to its effect on NKCC2), linking tyrosine phosphorylation to differential regulation of cotransporter surface expression.","method":"SYK depletion (siRNA/pharmacological inhibitor), constitutively active SYK overexpression, plasma membrane abundance quantification in HEK cells","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — cell-based gain and loss of function experiments with surface abundance readout, single lab","pmids":["31145900"],"is_preprint":false},{"year":2020,"finding":"KCC3 knockout dorsal root ganglion neurons swell but fail to undergo regulatory volume decrease under hypotonic challenge, while neurons expressing constitutively active KCC3 show blunted swelling, directly demonstrating KCC3's integral role in cell volume homeostasis in sensory neurons.","method":"Wide-field microscopy with calcein fluorescence, cell volume measurements in DRG neurons from wild-type, KCC3 LOF, and KCC3 GOF mouse lines","journal":"Cellular physiology and biochemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct cell volume measurements comparing LOF and GOF models, multiple genetic backgrounds","pmids":["32506846"],"is_preprint":false},{"year":2021,"finding":"ZnR/GPR39 activation by Zn2+ recruits KCC3 into F-actin-rich membrane protrusions, promotes F-actin stress fiber formation, and activates MMP2 and MMP9 in a KCC3-dependent manner; KCC3 silencing reverses ZnR/GPR39-enhanced cell proliferation, migration, and invasion.","method":"KCC3 siRNA knockdown, immunofluorescence (KCC3 localization in protrusions), gelatin zymography (MMP2/MMP9), Matrigel invasion assay, ZnR/GPR39 activation","journal":"Cell calcium","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization experiment showing receptor-dependent KCC3 redistribution, supported by functional siRNA knockdown data, single lab","pmids":["33465674"],"is_preprint":false},{"year":2022,"finding":"The KCC3a isoform is specifically expressed in type-B and non-A/non-B intercalated cells of the kidney connecting tubule (colocalizing with apical V-ATPase and pendrin), and its protein abundance is upregulated by metabolic alkalosis (NaHCO3), volume depletion (water restriction, low-salt diet), hydrochlorothiazide, amiloride, or K+-deficient diet.","method":"KCC3a-specific polyclonal antibody, immunofluorescence co-staining with cell-type markers (NCC, ENaC, calbindin, V-ATPase, pendrin), immunoblotting in wild-type and treated mice","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with validated isoform-specific antibody and multiple cell-type markers, single lab","pmids":["35874803"],"is_preprint":false},{"year":2023,"finding":"Bicarbonate ion itself directly increases KCC3a protein abundance in type-B intercalated cells through a posttranscriptional mechanism (mRNA unchanged), independently of aldosterone, angiotensin II, or direct interaction with pendrin, as shown in wild-type and pendrin knockout mice.","method":"In vivo dietary NaHCO3/KHCO3 loading, immunoblotting, KCC3a abundance in pendrin knockout mice, in vitro bicarbonate treatment","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (pendrin KO) and pharmacological dissection of mechanism, posttranscriptional nature confirmed by unchanged mRNA, single lab","pmids":["37036298"],"is_preprint":false},{"year":2021,"finding":"Disrupting KCC3 expression in adult mice or re-expressing KCC3 in adult mice that developed without functional KCC3 has no effect on locomotor behavior, indicating that KCC3 function is critical specifically during embryonic/perinatal development and that the disease is irreversible once established.","method":"PV-CreERT2 tamoxifen-inducible system for temporal control of KCC3 deletion and re-expression; rotarod and gait behavioral testing","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible genetic system testing temporal requirement, single lab","pmids":["33596149"],"is_preprint":false},{"year":2025,"finding":"DCT-specific deletion of KCC3 reduces both total and phosphorylated NCC protein levels and NCC mRNA, indicating that KCC3 plays a role in basal regulation of NCC expression in the distal convoluted tubule, but KCC3 is not required for DCT adaptation to dietary K+ depletion.","method":"DCT-specific KCC3 conditional knockout mouse, immunoblotting for NCC and phospho-NCC, RT-qPCR for NCC mRNA, blood electrolyte measurements under standard and K+-deficient diet","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO with molecular readouts, single lab","pmids":["40875335"],"is_preprint":false},{"year":2025,"finding":"A missense mutation p.H371R in SLC12A6 causes cytoplasmic mislocalization of the KCC3 protein (despite normal transcript and protein levels), disrupting ion transport function and leading to imbalanced intracellular K+ and Cl- levels and elevated cellular senescence markers (p16, p21).","method":"Functional analysis in patient cells: immunofluorescence for KCC3 subcellular localization, ion concentration measurement, Western blot for p16/p21, bioinformatics structural modeling","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — patient cell-based localization and functional analysis, structural modeling is computational, single study","pmids":["39988558"],"is_preprint":false}],"current_model":"SLC12A6/KCC3 is an electroneutral K+-Cl- cotransporter with 12 transmembrane domains that mediates coupled efflux of K+ and Cl- to regulate cell volume and intracellular chloride; its activity is controlled by a multi-site phosphorylation switch in which WNK kinases (via SPAK/MO25) phosphorylate Ser-96, Thr-991, and Thr-1048 to tonically inhibit the transporter under isotonic conditions, while cell swelling triggers dephosphorylation at all three sites to activate transport and drive regulatory volume decrease; two major isoforms (KCC3a/KCC3b) are generated from alternative promoters and show tissue-specific expression (KCC3a in brain/intercalated cells, KCC3b in kidney proximal tubule); neuronal KCC3 (particularly in parvalbumin-positive neurons) is essential during perinatal development for axon volume homeostasis in the peripheral nervous system, and loss-of-function mutations cause HMSN/ACC by disrupting this function, while gain-of-function (constitutive activity) also causes peripheral neuropathy by excessively depleting cell volume, demonstrating that finely tuned transporter activity is required for axonal health."},"narrative":{"mechanistic_narrative":"SLC12A6 encodes KCC3, an electroneutral K+-Cl- cotransporter that couples K+ and Cl- efflux to drive regulatory volume decrease and set intracellular chloride [PMID:10347194, PMID:32506846]. The protein adopts a 12-transmembrane topology with a large TM5-TM6 extracellular loop and extensive cytoplasmic N- and C-termini, and is activated specifically by cell swelling, with greater volume sensitivity than KCC1 [PMID:10347194, PMID:10600773]. KCC3 activity is governed by a multi-site phosphorylation switch: WNK3, acting with the SPAK/MO25 kinase module, phosphorylates Ser-96, Thr-991, and Thr-1048 to hold the transporter inactive under isotonic conditions, while swelling-triggered dephosphorylation at these sites activates transport; combined alanine substitution renders KCC3 constitutively active and refractory to hypotonicity [PMID:24043619, PMID:26217182]. Surface abundance is independently tuned by tyrosine phosphorylation, including SYK-mediated phosphorylation of an N-terminal tyrosine that reduces plasma membrane levels [PMID:31145900]. Alternative promoter usage and splicing generate multiple N-terminal isoforms with tissue-specific distribution — brain-predominant KCC3a and kidney proximal tubule basolateral KCC3b — all swelling-activated [PMID:11246162, PMID:16048901]. KCC3 is essential for cell volume homeostasis in neurons and renal tubules: in peripheral nerve it controls axon volume during early postnatal development, and its loss causes axonal swelling preceding myelin degeneration [PMID:17659877, PMID:32506846]. Both loss-of-function (e.g. the ACCPN-causing 2436delG truncation) and gain-of-function (constitutive T991A activity) disrupt this finely tuned volume control to cause peripheral neuropathy, the latter by excessively depleting intracellular K+ [PMID:12368912, PMID:26217182, PMID:27485015]. Loss of KCC3 specifically in parvalbumin-positive neurons during a critical perinatal window produces the locomotor deficits of HMSN/ACC (ACCPN), and the disease is irreversible once established [PMID:25116249, PMID:33596149]. KCC3 also contributes to renal ion handling and blood pressure, with knockout hypertension being neurogenic in origin via elevated sympathetic tone [PMID:16424367, PMID:35874803].","teleology":[{"year":1999,"claim":"Established the fundamental molecular identity of KCC3 as a swelling-activated K+-Cl- cotransporter, defining the biochemical activity that all later regulation and disease work builds on.","evidence":"Heterologous expression in Xenopus oocytes and HEK-293 cells with 86Rb+ flux assays and hydropathy analysis","pmids":["10347194","10600773"],"confidence":"High","gaps":["No structure of the transporter resolved","Endogenous physiological substrate concentrations not addressed"]},{"year":2001,"claim":"Mapped KCC3 expression to specific CNS structures and resolved two tissue-specific isoforms, framing how a single gene serves distinct neuronal and renal roles.","evidence":"KCC3-specific antibody Western blot, Northern blot, and immunofluorescence of mouse brain","pmids":["11246162"],"confidence":"Medium","gaps":["Functional difference between isoforms not yet tested","Single-lab antibody characterization"]},{"year":2002,"claim":"Linked KCC3 to human disease (ACCPN) and to nervous system development, showing a membrane-localized but transport-dead mutant and a knockout neuropathy phenotype — separating trafficking from function.","evidence":"Oocyte reconstitution of disease mutant plus targeted Slc12a6 deletion in mice with behavioral/electrophysiological phenotyping","pmids":["12368912"],"confidence":"High","gaps":["Did not identify the cell type responsible for neuropathy","Did not define the molecular switch controlling activity"]},{"year":2003,"claim":"Demonstrated that KCC3 loss impairs cell volume regulation across renal tubules and neurons and produces multi-system pathology, establishing volume homeostasis as the core in vivo function.","evidence":"Independent KCC3 knockout mouse with cell volume measurements, electrocorticogram, blood pressure, and inner ear morphology","pmids":["14532115"],"confidence":"High","gaps":["Origin of hypertension not yet determined","Cell-autonomous vs systemic contributions unresolved"]},{"year":2005,"claim":"Defined the full isoform repertoire, transport kinetics, and renal localization, refining the molecular and tissue-level picture of KCC3.","evidence":"Northern/Western blot, kidney immunofluorescence, and kinetic 86Rb+ flux in oocytes","pmids":["16048901"],"confidence":"High","gaps":["Functional specialization of minor isoforms unclear"]},{"year":2006,"claim":"Resolved the origin of knockout hypertension as neurogenic rather than vascular-intrinsic, showing KCC3 acts on the nervous system to set sympathetic tone.","evidence":"VSMC Cl- measurement, ex vivo vascular reactivity, in vivo adrenergic/ganglionic blockade, urinary catecholamines in KCC3 KO mice","pmids":["16424367"],"confidence":"High","gaps":["Specific neuronal circuit mediating sympathetic activation not identified"]},{"year":2007,"claim":"Pinpointed the temporal and cellular sequence of peripheral nerve pathology — axonal swelling preceding myelin loss — implicating volume dysregulation as the primary insult.","evidence":"Morphometry of sciatic nerve across postnatal timepoints, nerve conduction velocity, and IGF-1 pathway analysis in KCC3 KO mice and cell models","pmids":["17659877","17133354"],"confidence":"High","gaps":["Did not establish which nerve cell type requires KCC3","Link between proliferative signaling and neuropathy unclear"]},{"year":2012,"claim":"Genetically dissected neuronal versus non-neuronal KCC3 contributions, attributing neuropathy to neuronal axon volume control and auditory deficits to non-neuronal cells, and confirmed Cl- extrusion in sensory neurons.","evidence":"Conditional Cre/loxP mice and gramicidin-perforated patch clamp in KCC3-/- DRG neurons","pmids":["22423107","22609694"],"confidence":"High","gaps":["Did not yet pinpoint the exact neuronal subtype driving locomotor disease"]},{"year":2013,"claim":"Identified trafficking determinants and a dominant-negative mechanism via heterodimerization, showing how mislocalizing mutations impair both KCC3 and partner cotransporters.","evidence":"Co-immunoprecipitation with KCC2, glycosylation/confocal trafficking analysis, and oocyte function for the E289G mutant","pmids":["23593405"],"confidence":"High","gaps":["Physiological relevance of KCC3-KCC2 heterodimers in vivo not shown","Single-lab data"]},{"year":2013,"claim":"Defined the phosphoregulatory switch by identifying SPAK/MO25- and WNK3-dependent phosphosites that tonically inhibit the transporter, explaining how activity is coupled to cell volume.","evidence":"In vitro kinase assays, site-directed mutagenesis of Ser-96/Thr-991/Thr-1048, and oocyte/HEK293 functional validation","pmids":["24043619"],"confidence":"High","gaps":["Identity of the activating phosphatase not established","In vivo phosphosite occupancy not measured"]},{"year":2014,"claim":"Established Thr-991/Thr-1048 as a potent activity switch capable of 25-fold activation and depletion of intracellular K+, and identified the parvalbumin-positive neuron as the critical cell type for ACCPN.","evidence":"Mutagenesis with K+/transport assays and pharmacological dissection; four cell-type-specific Cre/loxP knockout lines with locomotor testing; KCC3-driven NF-κB/SPAK tumor signaling","pmids":["26217182","25116249","24655550"],"confidence":"High","gaps":["Mechanism linking PV neuron volume defect to motor circuitry dysfunction unresolved"]},{"year":2016,"claim":"Demonstrated that gain-of-function over-activation of KCC3 is itself pathogenic, establishing that both excess and absence of transport cause neurodegeneration via volume imbalance.","evidence":"Exome sequencing of a patient, patient-cell volume assay, and T991A/T1048A knock-in mice with electrophysiology and histopathology","pmids":["27485015"],"confidence":"High","gaps":["Why constitutive K+ loss is selectively neurotoxic not fully mechanistic"]},{"year":2019,"claim":"Showed that tyrosine phosphorylation by SYK controls KCC3 surface abundance, adding a membrane-trafficking layer distinct from the WNK/SPAK serine/threonine switch.","evidence":"SYK depletion/inhibition and constitutively active SYK overexpression with plasma membrane abundance quantification in HEK cells","pmids":["31145900"],"confidence":"Medium","gaps":["The specific tyrosine residue not definitively mapped in narrative detail","In vivo relevance untested"]},{"year":2020,"claim":"Directly visualized that KCC3 LOF abolishes regulatory volume decrease while GOF blunts swelling in sensory neurons, cementing the bidirectional role of KCC3 in neuronal volume homeostasis.","evidence":"Calcein wide-field cell volume imaging in DRG neurons from WT, LOF, and GOF mouse lines","pmids":["32506846"],"confidence":"High","gaps":["Did not connect single-cell volume defect to whole-organism phenotype timing"]},{"year":2021,"claim":"Defined the developmental window of KCC3 requirement, showing function is needed perinatally and that disease is irreversible, with implications for therapeutic timing.","evidence":"Tamoxifen-inducible PV-CreERT2 deletion/re-expression in adult mice with rotarod and gait testing; ZnR/GPR39-driven KCC3 recruitment to protrusions in cancer cells","pmids":["33596149","33465674"],"confidence":"Medium","gaps":["Molecular basis of the irreversibility not defined","Adult re-expression rescue mechanism unexplored"]},{"year":2023,"claim":"Characterized renal KCC3a regulation, localizing it to specific intercalated cells and showing posttranscriptional upregulation by bicarbonate and volume status independent of pendrin and aldosterone.","evidence":"Isoform-specific antibody immunofluorescence, dietary loading, and immunoblotting in WT and pendrin KO mice","pmids":["35874803","37036298"],"confidence":"Medium","gaps":["Posttranscriptional mechanism stabilizing KCC3a protein unidentified","Functional role in acid-base handling not directly tested"]},{"year":2025,"claim":"Extended KCC3's renal role to basal NCC regulation in the distal convoluted tubule and identified an additional mislocalizing disease mutation linking KCC3 dysfunction to cellular senescence.","evidence":"DCT-specific conditional KO with NCC immunoblotting/RT-qPCR; patient-cell localization, ion measurement, and senescence marker analysis for p.H371R","pmids":["40875335","39988558"],"confidence":"Medium","gaps":["Mechanism by which KCC3 controls NCC expression unknown","Causal link between mislocalization and senescence not mechanistically established"]},{"year":null,"claim":"It remains unresolved how perinatal KCC3-dependent volume control becomes permanently fixed into irreversible axonal pathology, and what phosphatase/upstream signals reverse the WNK/SPAK inhibitory phosphorylation during swelling.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Activating phosphatase for Ser-96/Thr-991/Thr-1048 not identified","Molecular basis of developmental irreversibility unknown","No high-resolution structure of human KCC3"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,7,17,20]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,12,20]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,5,7,19,22]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[13,26]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,7,17]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[9,11,12,15]}],"complexes":[],"partners":["KCC2","SPAK","WNK3","MO25","SYK"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UHW9","full_name":"Solute carrier family 12 member 6","aliases":["Electroneutral potassium-chloride cotransporter 3","K-Cl cotransporter 3"],"length_aa":1150,"mass_kda":127.6,"function":"Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:10600773, PubMed:11551954, PubMed:16048901, PubMed:18566107, PubMed:19665974, PubMed:21628467, PubMed:27485015). May contribute to cell volume homeostasis in single cells (PubMed:16048901, PubMed:27485015) Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901, PubMed:33199848, PubMed:34031912). May contribute to cell volume homeostasis in single cells (Probable) Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901). May contribute to cell volume homeostasis in single cells (Probable) Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901). May contribute to cell volume homeostasis in single cells (Probable) Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901). May contribute to cell volume homeostasis in single cells (Probable) Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901). May contribute to cell volume homeostasis in single cells (Probable)","subcellular_location":"Cell membrane; Basolateral cell membrane","url":"https://www.uniprot.org/uniprotkb/Q9UHW9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC12A6","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC12A6","total_profiled":1310},"omim":[{"mim_id":"620068","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2II; CMT2II","url":"https://www.omim.org/entry/620068"},{"mim_id":"606726","title":"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 5; SLC12A5","url":"https://www.omim.org/entry/606726"},{"mim_id":"604879","title":"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 7; SLC12A7","url":"https://www.omim.org/entry/604879"},{"mim_id":"604878","title":"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 6; SLC12A6","url":"https://www.omim.org/entry/604878"},{"mim_id":"604360","title":"SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11","url":"https://www.omim.org/entry/604360"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SLC12A6"},"hgnc":{"alias_symbol":["KCC3A","KCC3B"],"prev_symbol":["KCC3","ACCPN"]},"alphafold":{"accession":"Q9UHW9","domains":[{"cath_id":"1.20.1740.10","chopping":"162-169_181-371_484-698","consensus_level":"medium","plddt":92.2784,"start":162,"end":698},{"cath_id":"3.40.50","chopping":"751-864","consensus_level":"medium","plddt":92.5933,"start":751,"end":864},{"cath_id":"3.40.50","chopping":"905-1022_1078-1145","consensus_level":"medium","plddt":83.6737,"start":905,"end":1145}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UHW9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHW9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHW9-F1-predicted_aligned_error_v6.png","plddt_mean":79.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC12A6","jax_strain_url":"https://www.jax.org/strain/search?query=SLC12A6"},"sequence":{"accession":"Q9UHW9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UHW9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UHW9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UHW9"}},"corpus_meta":[{"pmid":"10347194","id":"PMC_10347194","title":"Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10347194","citation_count":249,"is_preprint":false},{"pmid":"12368912","id":"PMC_12368912","title":"The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12368912","citation_count":217,"is_preprint":false},{"pmid":"14532115","id":"PMC_14532115","title":"Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14532115","citation_count":177,"is_preprint":false},{"pmid":"10600773","id":"PMC_10600773","title":"Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10600773","citation_count":143,"is_preprint":false},{"pmid":"11246162","id":"PMC_11246162","title":"Localization of the K(+)-Cl(-) cotransporter, KCC3, in the central and peripheral nervous systems: expression in the choroid plexus, large neurons and white matter tracts.","date":"2001","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11246162","citation_count":102,"is_preprint":false},{"pmid":"11724933","id":"PMC_11724933","title":"The KCl cotransporter isoform KCC3 can play an important role in cell growth regulation.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11724933","citation_count":76,"is_preprint":false},{"pmid":"16048901","id":"PMC_16048901","title":"NH2-terminal heterogeneity in the KCC3 K+-Cl- cotransporter.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16048901","citation_count":65,"is_preprint":false},{"pmid":"17659877","id":"PMC_17659877","title":"Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice.","date":"2007","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/17659877","citation_count":64,"is_preprint":false},{"pmid":"16606917","id":"PMC_16606917","title":"Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndrome.","date":"2006","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16606917","citation_count":55,"is_preprint":false},{"pmid":"27485015","id":"PMC_27485015","title":"Peripheral motor neuropathy is associated with defective kinase regulation of the KCC3 cotransporter.","date":"2016","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27485015","citation_count":44,"is_preprint":false},{"pmid":"16424367","id":"PMC_16424367","title":"Neurogenic mechanisms contribute to hypertension in mice with disruption of the K-Cl cotransporter KCC3.","date":"2006","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16424367","citation_count":43,"is_preprint":false},{"pmid":"24043619","id":"PMC_24043619","title":"N-terminal serine dephosphorylation is required for KCC3 cotransporter full activation by cell swelling.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24043619","citation_count":35,"is_preprint":false},{"pmid":"17133354","id":"PMC_17133354","title":"IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness.","date":"2007","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17133354","citation_count":34,"is_preprint":false},{"pmid":"12712325","id":"PMC_12712325","title":"Differential expression pattern of chloride transporters NCC, NKCC2, KCC1, KCC3, KCC4, and AE3 in the developing rat auditory brainstem.","date":"2003","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/12712325","citation_count":34,"is_preprint":false},{"pmid":"22423107","id":"PMC_22423107","title":"Loss of neuronal potassium/chloride cotransporter 3 (KCC3) is responsible for the degenerative phenotype in a conditional mouse model of hereditary motor and sensory neuropathy associated with agenesis of the corpus callosum.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22423107","citation_count":30,"is_preprint":false},{"pmid":"18536702","id":"PMC_18536702","title":"Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional DNA methylation site.","date":"2008","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18536702","citation_count":29,"is_preprint":false},{"pmid":"16872584","id":"PMC_16872584","title":"KCC3 and KCC4 expression in rat adult forebrain.","date":"2006","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16872584","citation_count":25,"is_preprint":false},{"pmid":"26217182","id":"PMC_26217182","title":"Regulated phosphorylation of the K-Cl cotransporter KCC3 is a molecular switch of intracellular potassium content and cell volume homeostasis.","date":"2015","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26217182","citation_count":25,"is_preprint":false},{"pmid":"23593405","id":"PMC_23593405","title":"A trafficking-deficient mutant of KCC3 reveals dominant-negative effects on K-Cl cotransport function.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23593405","citation_count":25,"is_preprint":false},{"pmid":"25116249","id":"PMC_25116249","title":"Deletion of KCC3 in parvalbumin neurons leads to locomotor deficit in a conditional mouse model of peripheral neuropathy associated with agenesis of the corpus callosum.","date":"2014","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/25116249","citation_count":24,"is_preprint":false},{"pmid":"14732340","id":"PMC_14732340","title":"The NO signaling pathway differentially regulates KCC3a and KCC3b mRNA expression.","date":"2003","source":"Nitric oxide : biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14732340","citation_count":23,"is_preprint":false},{"pmid":"17893295","id":"PMC_17893295","title":"Distal truncation of KCC3 in non-French Canadian HMSN/ACC families.","date":"2007","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17893295","citation_count":21,"is_preprint":false},{"pmid":"29366908","id":"PMC_29366908","title":"A role for KCC3 in maintaining cell volume of peripheral nerve fibers.","date":"2018","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/29366908","citation_count":19,"is_preprint":false},{"pmid":"22609694","id":"PMC_22609694","title":"KCC3-dependent chloride extrusion in adult sensory neurons.","date":"2012","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/22609694","citation_count":19,"is_preprint":false},{"pmid":"24655550","id":"PMC_24655550","title":"SPAK mediates KCC3-enhanced cervical cancer tumorigenesis.","date":"2014","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/24655550","citation_count":17,"is_preprint":false},{"pmid":"21147077","id":"PMC_21147077","title":"Cellular expression of the K+-Cl- cotransporter KCC3 in the central nervous system of mouse.","date":"2010","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/21147077","citation_count":17,"is_preprint":false},{"pmid":"11325574","id":"PMC_11325574","title":"Mutation analysis of the potassium chloride cotransporter KCC3 (SLC12A6) in rolandic and idiopathic generalized epilepsy.","date":"2001","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/11325574","citation_count":17,"is_preprint":false},{"pmid":"20020398","id":"PMC_20020398","title":"Andermann syndrome can be a phenocopy of hereditary motor and sensory neuropathy--report of a discordant sibship with a compound heterozygous mutation of the KCC3 gene.","date":"2009","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/20020398","citation_count":16,"is_preprint":false},{"pmid":"35874803","id":"PMC_35874803","title":"KCC3a, a Strong Candidate Pathway for K+ Loss in Alkalemia.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35874803","citation_count":15,"is_preprint":false},{"pmid":"38421867","id":"PMC_38421867","title":"Neuron cilia restrain glial KCC-3 to a microdomain to regulate multisensory processing.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/38421867","citation_count":13,"is_preprint":false},{"pmid":"22776998","id":"PMC_22776998","title":"High-grade glioma motility reduced by genetic knockdown of KCC3.","date":"2012","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22776998","citation_count":12,"is_preprint":false},{"pmid":"37036298","id":"PMC_37036298","title":"Bicarbonate is the primary inducer of KCC3a expression in renal cortical B-type intercalated cells.","date":"2023","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37036298","citation_count":9,"is_preprint":false},{"pmid":"33465674","id":"PMC_33465674","title":"ZnR/GPR39 controls cell migration by orchestrating recruitment of KCC3 into protrusions, re-organization of actin and activation of MMP.","date":"2021","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/33465674","citation_count":8,"is_preprint":false},{"pmid":"27230413","id":"PMC_27230413","title":"KCC3 axonopathy: neuropathological features in the central and peripheral nervous system.","date":"2016","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/27230413","citation_count":8,"is_preprint":false},{"pmid":"31145900","id":"PMC_31145900","title":"Tyrosine phosphorylation modulates cell surface expression of chloride cotransporters NKCC2 and KCC3.","date":"2019","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/31145900","citation_count":7,"is_preprint":false},{"pmid":"18343091","id":"PMC_18343091","title":"A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice.","date":"2008","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18343091","citation_count":7,"is_preprint":false},{"pmid":"36542484","id":"PMC_36542484","title":"Late-onset sensory-motor axonal neuropathy, a novel SLC12A6-related phenotype.","date":"2023","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36542484","citation_count":6,"is_preprint":false},{"pmid":"35733399","id":"PMC_35733399","title":"Novel heterozygous variants of SLC12A6 in Japanese families with Charcot-Marie-Tooth disease.","date":"2022","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35733399","citation_count":5,"is_preprint":false},{"pmid":"33323309","id":"PMC_33323309","title":"Whole-exome sequencing identifies a heterozygous mutation in SLC12A6 associated with hereditary sensory and motor neuropathy.","date":"2020","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/33323309","citation_count":5,"is_preprint":false},{"pmid":"32506846","id":"PMC_32506846","title":"Osmotic Response of Dorsal Root Ganglion Neurons Expressing Wild-Type and Mutant KCC3 Transporters.","date":"2020","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32506846","citation_count":5,"is_preprint":false},{"pmid":"34706912","id":"PMC_34706912","title":"Expanding the phenotype of SLC12A6-associated sensorimotor neuropathy.","date":"2021","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/34706912","citation_count":4,"is_preprint":false},{"pmid":"32765936","id":"PMC_32765936","title":"A Novel Splice-Site Variant in SLC12A6 Causes Andermann Syndrome without Agenesis of the Corpus Callosum.","date":"2020","source":"Journal of pediatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32765936","citation_count":4,"is_preprint":false},{"pmid":"35274823","id":"PMC_35274823","title":"Erythroid-specific inactivation of Slc12a6/Kcc3 by EpoR promoter-driven Cre expression reduces K-Cl cotransport activity in mouse erythrocytes.","date":"2022","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/35274823","citation_count":3,"is_preprint":false},{"pmid":"30868738","id":"PMC_30868738","title":"First case of Roma ethnic origin with Andermann syndrome: A novel frameshift mutation in exon 20 of SLC12A6 gene.","date":"2019","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30868738","citation_count":3,"is_preprint":false},{"pmid":"33596149","id":"PMC_33596149","title":"Temporal manipulation of KCC3 expression in juvenile or adult mice suggests irreversible developmental deficit in hereditary motor sensory neuropathy with agenesis of the corpus callosum.","date":"2021","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33596149","citation_count":2,"is_preprint":false},{"pmid":"41500801","id":"PMC_41500801","title":"Spectrum of dominant Charcot-Marie-Tooth disease due to SLC12A6 variants.","date":"2026","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/41500801","citation_count":1,"is_preprint":false},{"pmid":"40009635","id":"PMC_40009635","title":"A \"Knob Switch\" Model for the Phosphoregulatory Mechanism of KCC3 at the Carboxy-Terminal Domain.","date":"2025","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40009635","citation_count":1,"is_preprint":false},{"pmid":"40875335","id":"PMC_40875335","title":"KCC3 is not required for the distal convoluted tubule response to reduced dietary potassium intake.","date":"2025","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/40875335","citation_count":0,"is_preprint":false},{"pmid":"39988558","id":"PMC_39988558","title":"A Novel Missense Mutation in SLC12A6 Impairs Ion Transport Function of the Protein to Cause Agenesis of the Corpus Callosum With Peripheral Neuropathy.","date":"2025","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39988558","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.20.677403","title":"Pooled CRISPR screens identify genes and non-coding genomic regions that regulate red blood cell density","date":"2025-09-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.20.677403","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.11.25331388","title":"Frequency enrichment of coding variants in a French-Canadian founder population and its implication for inflammatory bowel diseases","date":"2025-07-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.11.25331388","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26582,"output_tokens":6771,"usd":0.090655,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15894,"output_tokens":5124,"usd":0.103785,"stage2_stop_reason":"end_turn"},"total_usd":0.19444,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"KCC3 functions as a K+-Cl- cotransporter: expression in Xenopus laevis oocytes demonstrated Cl--dependent uptake of 86Rb+ that is strongly activated by cell swelling and weakly sensitive to furosemide. KCC3 has greater volume sensitivity than KCC1.\",\n      \"method\": \"Heterologous expression in Xenopus laevis oocytes, 86Rb+ flux assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro functional reconstitution in oocytes with ion flux assay, replicated by multiple independent groups\",\n      \"pmids\": [\"10347194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"KCC3 protein has 12 predicted transmembrane domains, a large extracellular loop between TM5 and TM6, and large NH2- and COOH-terminal cytoplasmic domains. It is activated by cell swelling, N-ethylmaleimide treatment, and staurosporine when transiently expressed in HEK-293 cells.\",\n      \"method\": \"Hydropathy analysis, transient transfection in HEK-293 cells, ion transport assay\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — functional characterization in mammalian cells with multiple activating conditions, independently confirmed\",\n      \"pmids\": [\"10600773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A truncating frameshift mutation in KCC3 (2436delG, Thr813fsX813) causing ACCPN produces a protein that is correctly glycosylated and expressed at the plasma membrane but is non-functional as a K+-Cl- cotransporter.\",\n      \"method\": \"Heterologous expression of wild-type and mutant KCC3 in Xenopus laevis oocytes, ion flux assay, glycosylation analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution of mutant vs. wild-type in oocytes with flux assay plus biochemical characterization, disease-linked mutation\",\n      \"pmids\": [\"12368912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Mice with targeted deletion of Slc12a6 (KCC3 knockout) develop locomotor deficit, peripheral neuropathy, and sensorimotor gating deficit, demonstrating a critical role for KCC3 in development and maintenance of the nervous system.\",\n      \"method\": \"Targeted gene deletion in mice, behavioral and electrophysiological phenotyping\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout mouse with defined neurological phenotype, replicated by independent groups\",\n      \"pmids\": [\"12368912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"KCC3 knockout mice show severely impaired cell volume regulation in renal tubules and neurons, moderately raised intraneuronal Cl- concentration, progressive neurodegeneration of peripheral and central nervous system, reduced seizure threshold, arterial hypertension, and slowly progressive deafness with degeneration of inner ear K+ recycling pathway cells.\",\n      \"method\": \"Targeted gene disruption in mice, cell volume measurements, electrocorticogram, blood pressure measurement, morphological analysis of inner ear\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independent KCC3 knockout mouse line with multiple orthogonal functional readouts, replicates findings from PMID:12368912\",\n      \"pmids\": [\"14532115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"KCC3 is localized to myelin sheaths in spinal cord white matter tracts, pyramidal neurons, Purkinje cells, and the base of choroid plexus epithelium in mouse CNS. Two distinct protein isoforms (150 kDa in kidney, 170 kDa in brain) exist even after deglycosylation, corresponding to KCC3a (brain-predominant) and KCC3b (kidney-predominant) isoforms generated by alternative first coding exons.\",\n      \"method\": \"Western blot with KCC3-specific polyclonal antibody, Northern blot, immunofluorescence microscopy of mouse brain sections\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with antibody validation and Northern blot, single lab\",\n      \"pmids\": [\"11246162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"KCC3 expression and activity are regulated by tyrosine phosphorylation, and KCC3 promotes cell proliferation and cell cycle progression; IGF-1 upregulates KCC3 expression and stimulates growth, while TNF-alpha downregulates KCC3 and causes growth arrest.\",\n      \"method\": \"NIH/3T3 fibroblast expression system, DIOA inhibition, FACS cell cycle analysis, Western blot for Rb and cdc2 phosphorylation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (transport assay, FACS, Western blot) in single lab\",\n      \"pmids\": [\"11724933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"KCC3 has at least five NH2-terminal isoforms (KCC3a, KCC3b, KCC3a-x2M, KCC3b-x2M, KCC3a-S) generated by alternative promoter usage and splicing. All are activated by cell swelling but not under isotonic conditions. KCC3a kinetics: Km for Rb+ ~10.7 mM, Cl- ~7.3 mM; anion selectivity Br- > Cl- > PO4 = I- = SCN- = gluconate. KCC3b predominates in kidney proximal tubule at basolateral membrane.\",\n      \"method\": \"Northern blot, Western blot, immunofluorescence of mouse/rat kidney, functional expression in Xenopus laevis oocytes with 86Rb+ flux assay\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with kinetic characterization, direct localization, molecular characterization of isoforms, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16048901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Hypertension in KCC3 knockout mice is neurogenic in origin: intracellular Cl- is elevated in vascular smooth muscle cells, but isolated arteries show no intrinsic vascular defect. Alpha1-adrenergic blockade or ganglionic transmission inhibition abolishes the blood pressure difference, and urinary catecholamines are elevated, demonstrating that elevated sympathetic tone mediates the hypertension.\",\n      \"method\": \"Vascular smooth muscle cell Cl- measurements, ex vivo vascular reactivity assays, in vivo pharmacological blockade, urinary catecholamine measurement in KCC3 knockout mice\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal experimental approaches (intracellular Cl- measurement, ex vivo, in vivo pharmacology, biomarkers) in single KCC3 knockout model\",\n      \"pmids\": [\"16424367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"KCC3 is expressed in sciatic nerve during early postnatal development (juvenile but not adult wild-type mice). Loss of KCC3 causes initial axonal swelling at P3 (before myelin abnormalities), followed by periaxonal fluid accumulation, and ultimately axon and myelin degeneration in adults with reduced nerve conduction velocity, implicating cell volume regulation in peripheral nerve maintenance.\",\n      \"method\": \"KCC3 knockout mouse analysis, morphometric analysis of sciatic nerves at multiple postnatal timepoints, nerve conduction velocity measurement, immunohistochemistry\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic morphometric analysis with temporal resolution in KCC3 KO mice, multiple readouts\",\n      \"pmids\": [\"17659877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IGF-1 upregulates KCC3 expression through PI3K and MAPK signaling cascades at the transcriptional level (blocked by actinomycin D), and KCC3-dependent transport is required for IGF-1-stimulated breast cancer cell proliferation.\",\n      \"method\": \"siRNA knockdown, KCC3 overexpression, pharmacological pathway inhibition, actinomycin D transcription block, xenograft tumor assay in SCID mice\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (siRNA, OE, pharmacological inhibition, in vivo xenograft) in single lab\",\n      \"pmids\": [\"17133354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Neuronal-specific KCC3 expression is crucial for axon volume control and accounts for the neuropathic features of HMSN/ACC, while loss of non-neuronal KCC3 causes auditory impairment. KCC3 also plays an essential role in inflammatory pain pathways.\",\n      \"method\": \"Conditional Cre/LoxP transgenic mice (neuron-specific and ubiquitous truncated KCC3 expression), behavioral, electrophysiological, and histological phenotyping\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific knockout with multiple phenotypic readouts, dissects neuronal vs. non-neuronal contribution\",\n      \"pmids\": [\"22423107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"KCC3 contributes to Cl- extrusion in a subset of adult dorsal root ganglion sensory neurons, as demonstrated by gramicidin-perforated patch clamp in KCC3-/- mice showing failure of Cl- extrusion.\",\n      \"method\": \"Gramicidin-perforated patch-clamp recordings, quantitative RT-PCR, pharmacological inhibition with KCC cotransporter inhibitors in wild-type and KCC3-/- DRG neurons\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct electrophysiological measurement of Cl- in KCC3 knockout neurons with pharmacological controls\",\n      \"pmids\": [\"22609694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A glutamic acid residue (E289) is essential for proper trafficking and function of KCC3: the E289G mutation causes glycosylation deficiency, ER/early Golgi retention, and failure to reach the plasma membrane. This mutant KCC3 forms heterodimers with KCC2 (shown by co-immunoprecipitation) and exerts dominant-negative effects by preventing proper trafficking of co-expressed wild-type KCC cotransporters.\",\n      \"method\": \"Co-immunoprecipitation, glycosylation analysis, confocal microscopy of subcellular localization, functional assay in Xenopus oocytes\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP for heterodimer formation, biochemical trafficking analysis, functional oocyte assay, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"23593405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SPAK complexed with its regulatory MO25 subunit phosphorylates KCC3 at Ser-96 in vitro. In Xenopus oocytes, Ser-96 is phosphorylated under isotonic conditions and dephosphorylated during hypotonic conditions, contributing to full activation. WNK3 promotes phosphorylation of Ser-96 as well as Thr-991 and Thr-1048. The triple mutant KCC3-S96A/T991A/T1048A has constitutive activity not further increased by hypotonicity or inhibited by WNK3.\",\n      \"method\": \"In vitro kinase assay with SPAK/MO25, site-directed mutagenesis, functional expression in Xenopus oocytes, HEK293 cells stably expressing WNK3\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay identifies phosphorylation site, mutagenesis confirms functional role, oocyte and cell line validation\",\n      \"pmids\": [\"24043619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of KCC3 specifically in parvalbumin-positive neurons leads to significant locomotor deficit in mice, identifying this cell population as critical for the pathogenic development of ACCPN. Loss of KCC3 in nociceptive neurons (Nav1.8-Cre) or Schwann cells (desert hedgehog-Cre) did not produce the locomotor phenotype.\",\n      \"method\": \"Tissue-specific KCC3 knockout mouse lines using Cre/loxP system (parvalbumin-Cre, NSE-Cre, Nav1.8-Cre, dhh-Cre), locomotor behavioral testing\",\n      \"journal\": \"Behavioural brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — four different cell-type-specific knockout lines tested, positive and negative results establish cell-type specificity\",\n      \"pmids\": [\"25116249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"KCC3 overexpression activates NF-κB and SPAK signaling, leading to p38 MAPK activation and MMP2 upregulation; SPAK is required for KCC3-mediated tumor cell invasiveness. NF-κB binds to the SPAK promoter in KCC3-overexpressing cells.\",\n      \"method\": \"siRNA knockdown, RT-PCR, NF-κB luciferase reporter assay, chromatin immunoprecipitation, gelatin zymography, mouse xenograft assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (ChIP, luciferase, gelatin zymography, in vivo xenograft) in single lab establishing pathway placement\",\n      \"pmids\": [\"24655550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Phosphorylation of Thr-991 and Thr-1048 in the KCC3a C-terminus constitutes a potent molecular switch: alanine substitution at both sites (T991A/T1048A) activates KCC3a up to 25-fold under normally inhibitory isotonic conditions and is accompanied by reversal of NKCC1 activity, causing rapid and substantial reduction in intracellular K+ content via both Cl-dependent and Cl-independent (VRAC-sensitive) pathways.\",\n      \"method\": \"Site-directed mutagenesis (T991A/T1048A), ion transport assay, intracellular K+ measurement, pharmacological inhibition (DCPIB for VRAC, bumetanide for NKCC1)\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional assay and pharmacological dissection of pathways, multiple orthogonal readouts\",\n      \"pmids\": [\"26217182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A de novo T991A mutation in KCC3 abolishes WNK kinase-dependent phosphorylation at Thr-991, resulting in constitutive KCC3 activity and compromised cell volume homeostasis. KCC3-T991A/T1048A knock-in mice exhibit constitutive KCC3 activity and recapitulate clinical features of the patient's progressive motor peripheral neuropathy, demonstrating that over-activation of KCC3 causes neurodegeneration.\",\n      \"method\": \"Exome sequencing (patient identification), cell volume assay in patient cells, KCC3-T991A/T1048A knock-in mouse generation, electrophysiological and histopathological analysis\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human mutation identified and functionally validated in patient cells and knock-in mouse model with multiple phenotypic readouts\",\n      \"pmids\": [\"27485015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Spleen tyrosine kinase (SYK) phosphorylates a specific N-terminal tyrosine residue of KCC3, and this phosphorylation decreases KCC3 abundance at the plasma membrane. SYK depletion or inhibition increases KCC3 membrane surface levels (opposite to its effect on NKCC2), linking tyrosine phosphorylation to differential regulation of cotransporter surface expression.\",\n      \"method\": \"SYK depletion (siRNA/pharmacological inhibitor), constitutively active SYK overexpression, plasma membrane abundance quantification in HEK cells\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — cell-based gain and loss of function experiments with surface abundance readout, single lab\",\n      \"pmids\": [\"31145900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"KCC3 knockout dorsal root ganglion neurons swell but fail to undergo regulatory volume decrease under hypotonic challenge, while neurons expressing constitutively active KCC3 show blunted swelling, directly demonstrating KCC3's integral role in cell volume homeostasis in sensory neurons.\",\n      \"method\": \"Wide-field microscopy with calcein fluorescence, cell volume measurements in DRG neurons from wild-type, KCC3 LOF, and KCC3 GOF mouse lines\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cell volume measurements comparing LOF and GOF models, multiple genetic backgrounds\",\n      \"pmids\": [\"32506846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ZnR/GPR39 activation by Zn2+ recruits KCC3 into F-actin-rich membrane protrusions, promotes F-actin stress fiber formation, and activates MMP2 and MMP9 in a KCC3-dependent manner; KCC3 silencing reverses ZnR/GPR39-enhanced cell proliferation, migration, and invasion.\",\n      \"method\": \"KCC3 siRNA knockdown, immunofluorescence (KCC3 localization in protrusions), gelatin zymography (MMP2/MMP9), Matrigel invasion assay, ZnR/GPR39 activation\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization experiment showing receptor-dependent KCC3 redistribution, supported by functional siRNA knockdown data, single lab\",\n      \"pmids\": [\"33465674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The KCC3a isoform is specifically expressed in type-B and non-A/non-B intercalated cells of the kidney connecting tubule (colocalizing with apical V-ATPase and pendrin), and its protein abundance is upregulated by metabolic alkalosis (NaHCO3), volume depletion (water restriction, low-salt diet), hydrochlorothiazide, amiloride, or K+-deficient diet.\",\n      \"method\": \"KCC3a-specific polyclonal antibody, immunofluorescence co-staining with cell-type markers (NCC, ENaC, calbindin, V-ATPase, pendrin), immunoblotting in wild-type and treated mice\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with validated isoform-specific antibody and multiple cell-type markers, single lab\",\n      \"pmids\": [\"35874803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Bicarbonate ion itself directly increases KCC3a protein abundance in type-B intercalated cells through a posttranscriptional mechanism (mRNA unchanged), independently of aldosterone, angiotensin II, or direct interaction with pendrin, as shown in wild-type and pendrin knockout mice.\",\n      \"method\": \"In vivo dietary NaHCO3/KHCO3 loading, immunoblotting, KCC3a abundance in pendrin knockout mice, in vitro bicarbonate treatment\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (pendrin KO) and pharmacological dissection of mechanism, posttranscriptional nature confirmed by unchanged mRNA, single lab\",\n      \"pmids\": [\"37036298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Disrupting KCC3 expression in adult mice or re-expressing KCC3 in adult mice that developed without functional KCC3 has no effect on locomotor behavior, indicating that KCC3 function is critical specifically during embryonic/perinatal development and that the disease is irreversible once established.\",\n      \"method\": \"PV-CreERT2 tamoxifen-inducible system for temporal control of KCC3 deletion and re-expression; rotarod and gait behavioral testing\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible genetic system testing temporal requirement, single lab\",\n      \"pmids\": [\"33596149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DCT-specific deletion of KCC3 reduces both total and phosphorylated NCC protein levels and NCC mRNA, indicating that KCC3 plays a role in basal regulation of NCC expression in the distal convoluted tubule, but KCC3 is not required for DCT adaptation to dietary K+ depletion.\",\n      \"method\": \"DCT-specific KCC3 conditional knockout mouse, immunoblotting for NCC and phospho-NCC, RT-qPCR for NCC mRNA, blood electrolyte measurements under standard and K+-deficient diet\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO with molecular readouts, single lab\",\n      \"pmids\": [\"40875335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A missense mutation p.H371R in SLC12A6 causes cytoplasmic mislocalization of the KCC3 protein (despite normal transcript and protein levels), disrupting ion transport function and leading to imbalanced intracellular K+ and Cl- levels and elevated cellular senescence markers (p16, p21).\",\n      \"method\": \"Functional analysis in patient cells: immunofluorescence for KCC3 subcellular localization, ion concentration measurement, Western blot for p16/p21, bioinformatics structural modeling\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — patient cell-based localization and functional analysis, structural modeling is computational, single study\",\n      \"pmids\": [\"39988558\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC12A6/KCC3 is an electroneutral K+-Cl- cotransporter with 12 transmembrane domains that mediates coupled efflux of K+ and Cl- to regulate cell volume and intracellular chloride; its activity is controlled by a multi-site phosphorylation switch in which WNK kinases (via SPAK/MO25) phosphorylate Ser-96, Thr-991, and Thr-1048 to tonically inhibit the transporter under isotonic conditions, while cell swelling triggers dephosphorylation at all three sites to activate transport and drive regulatory volume decrease; two major isoforms (KCC3a/KCC3b) are generated from alternative promoters and show tissue-specific expression (KCC3a in brain/intercalated cells, KCC3b in kidney proximal tubule); neuronal KCC3 (particularly in parvalbumin-positive neurons) is essential during perinatal development for axon volume homeostasis in the peripheral nervous system, and loss-of-function mutations cause HMSN/ACC by disrupting this function, while gain-of-function (constitutive activity) also causes peripheral neuropathy by excessively depleting cell volume, demonstrating that finely tuned transporter activity is required for axonal health.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC12A6 encodes KCC3, an electroneutral K+-Cl- cotransporter that couples K+ and Cl- efflux to drive regulatory volume decrease and set intracellular chloride [#0, #20]. The protein adopts a 12-transmembrane topology with a large TM5-TM6 extracellular loop and extensive cytoplasmic N- and C-termini, and is activated specifically by cell swelling, with greater volume sensitivity than KCC1 [#0, #1]. KCC3 activity is governed by a multi-site phosphorylation switch: WNK3, acting with the SPAK/MO25 kinase module, phosphorylates Ser-96, Thr-991, and Thr-1048 to hold the transporter inactive under isotonic conditions, while swelling-triggered dephosphorylation at these sites activates transport; combined alanine substitution renders KCC3 constitutively active and refractory to hypotonicity [#14, #17]. Surface abundance is independently tuned by tyrosine phosphorylation, including SYK-mediated phosphorylation of an N-terminal tyrosine that reduces plasma membrane levels [#19]. Alternative promoter usage and splicing generate multiple N-terminal isoforms with tissue-specific distribution \\u2014 brain-predominant KCC3a and kidney proximal tubule basolateral KCC3b \\u2014 all swelling-activated [#5, #7]. KCC3 is essential for cell volume homeostasis in neurons and renal tubules: in peripheral nerve it controls axon volume during early postnatal development, and its loss causes axonal swelling preceding myelin degeneration [#9, #20]. Both loss-of-function (e.g. the ACCPN-causing 2436delG truncation) and gain-of-function (constitutive T991A activity) disrupt this finely tuned volume control to cause peripheral neuropathy, the latter by excessively depleting intracellular K+ [#2, #17, #18]. Loss of KCC3 specifically in parvalbumin-positive neurons during a critical perinatal window produces the locomotor deficits of HMSN/ACC (ACCPN), and the disease is irreversible once established [#15, #24]. KCC3 also contributes to renal ion handling and blood pressure, with knockout hypertension being neurogenic in origin via elevated sympathetic tone [#8, #22].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the fundamental molecular identity of KCC3 as a swelling-activated K+-Cl- cotransporter, defining the biochemical activity that all later regulation and disease work builds on.\",\n      \"evidence\": \"Heterologous expression in Xenopus oocytes and HEK-293 cells with 86Rb+ flux assays and hydropathy analysis\",\n      \"pmids\": [\"10347194\", \"10600773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the transporter resolved\", \"Endogenous physiological substrate concentrations not addressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapped KCC3 expression to specific CNS structures and resolved two tissue-specific isoforms, framing how a single gene serves distinct neuronal and renal roles.\",\n      \"evidence\": \"KCC3-specific antibody Western blot, Northern blot, and immunofluorescence of mouse brain\",\n      \"pmids\": [\"11246162\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional difference between isoforms not yet tested\", \"Single-lab antibody characterization\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked KCC3 to human disease (ACCPN) and to nervous system development, showing a membrane-localized but transport-dead mutant and a knockout neuropathy phenotype \\u2014 separating trafficking from function.\",\n      \"evidence\": \"Oocyte reconstitution of disease mutant plus targeted Slc12a6 deletion in mice with behavioral/electrophysiological phenotyping\",\n      \"pmids\": [\"12368912\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the cell type responsible for neuropathy\", \"Did not define the molecular switch controlling activity\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated that KCC3 loss impairs cell volume regulation across renal tubules and neurons and produces multi-system pathology, establishing volume homeostasis as the core in vivo function.\",\n      \"evidence\": \"Independent KCC3 knockout mouse with cell volume measurements, electrocorticogram, blood pressure, and inner ear morphology\",\n      \"pmids\": [\"14532115\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Origin of hypertension not yet determined\", \"Cell-autonomous vs systemic contributions unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the full isoform repertoire, transport kinetics, and renal localization, refining the molecular and tissue-level picture of KCC3.\",\n      \"evidence\": \"Northern/Western blot, kidney immunofluorescence, and kinetic 86Rb+ flux in oocytes\",\n      \"pmids\": [\"16048901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional specialization of minor isoforms unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved the origin of knockout hypertension as neurogenic rather than vascular-intrinsic, showing KCC3 acts on the nervous system to set sympathetic tone.\",\n      \"evidence\": \"VSMC Cl- measurement, ex vivo vascular reactivity, in vivo adrenergic/ganglionic blockade, urinary catecholamines in KCC3 KO mice\",\n      \"pmids\": [\"16424367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific neuronal circuit mediating sympathetic activation not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Pinpointed the temporal and cellular sequence of peripheral nerve pathology \\u2014 axonal swelling preceding myelin loss \\u2014 implicating volume dysregulation as the primary insult.\",\n      \"evidence\": \"Morphometry of sciatic nerve across postnatal timepoints, nerve conduction velocity, and IGF-1 pathway analysis in KCC3 KO mice and cell models\",\n      \"pmids\": [\"17659877\", \"17133354\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish which nerve cell type requires KCC3\", \"Link between proliferative signaling and neuropathy unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Genetically dissected neuronal versus non-neuronal KCC3 contributions, attributing neuropathy to neuronal axon volume control and auditory deficits to non-neuronal cells, and confirmed Cl- extrusion in sensory neurons.\",\n      \"evidence\": \"Conditional Cre/loxP mice and gramicidin-perforated patch clamp in KCC3-/- DRG neurons\",\n      \"pmids\": [\"22423107\", \"22609694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not yet pinpoint the exact neuronal subtype driving locomotor disease\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified trafficking determinants and a dominant-negative mechanism via heterodimerization, showing how mislocalizing mutations impair both KCC3 and partner cotransporters.\",\n      \"evidence\": \"Co-immunoprecipitation with KCC2, glycosylation/confocal trafficking analysis, and oocyte function for the E289G mutant\",\n      \"pmids\": [\"23593405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of KCC3-KCC2 heterodimers in vivo not shown\", \"Single-lab data\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined the phosphoregulatory switch by identifying SPAK/MO25- and WNK3-dependent phosphosites that tonically inhibit the transporter, explaining how activity is coupled to cell volume.\",\n      \"evidence\": \"In vitro kinase assays, site-directed mutagenesis of Ser-96/Thr-991/Thr-1048, and oocyte/HEK293 functional validation\",\n      \"pmids\": [\"24043619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the activating phosphatase not established\", \"In vivo phosphosite occupancy not measured\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established Thr-991/Thr-1048 as a potent activity switch capable of 25-fold activation and depletion of intracellular K+, and identified the parvalbumin-positive neuron as the critical cell type for ACCPN.\",\n      \"evidence\": \"Mutagenesis with K+/transport assays and pharmacological dissection; four cell-type-specific Cre/loxP knockout lines with locomotor testing; KCC3-driven NF-\\u03baB/SPAK tumor signaling\",\n      \"pmids\": [\"26217182\", \"25116249\", \"24655550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking PV neuron volume defect to motor circuitry dysfunction unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated that gain-of-function over-activation of KCC3 is itself pathogenic, establishing that both excess and absence of transport cause neurodegeneration via volume imbalance.\",\n      \"evidence\": \"Exome sequencing of a patient, patient-cell volume assay, and T991A/T1048A knock-in mice with electrophysiology and histopathology\",\n      \"pmids\": [\"27485015\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why constitutive K+ loss is selectively neurotoxic not fully mechanistic\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed that tyrosine phosphorylation by SYK controls KCC3 surface abundance, adding a membrane-trafficking layer distinct from the WNK/SPAK serine/threonine switch.\",\n      \"evidence\": \"SYK depletion/inhibition and constitutively active SYK overexpression with plasma membrane abundance quantification in HEK cells\",\n      \"pmids\": [\"31145900\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The specific tyrosine residue not definitively mapped in narrative detail\", \"In vivo relevance untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Directly visualized that KCC3 LOF abolishes regulatory volume decrease while GOF blunts swelling in sensory neurons, cementing the bidirectional role of KCC3 in neuronal volume homeostasis.\",\n      \"evidence\": \"Calcein wide-field cell volume imaging in DRG neurons from WT, LOF, and GOF mouse lines\",\n      \"pmids\": [\"32506846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not connect single-cell volume defect to whole-organism phenotype timing\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined the developmental window of KCC3 requirement, showing function is needed perinatally and that disease is irreversible, with implications for therapeutic timing.\",\n      \"evidence\": \"Tamoxifen-inducible PV-CreERT2 deletion/re-expression in adult mice with rotarod and gait testing; ZnR/GPR39-driven KCC3 recruitment to protrusions in cancer cells\",\n      \"pmids\": [\"33596149\", \"33465674\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of the irreversibility not defined\", \"Adult re-expression rescue mechanism unexplored\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Characterized renal KCC3a regulation, localizing it to specific intercalated cells and showing posttranscriptional upregulation by bicarbonate and volume status independent of pendrin and aldosterone.\",\n      \"evidence\": \"Isoform-specific antibody immunofluorescence, dietary loading, and immunoblotting in WT and pendrin KO mice\",\n      \"pmids\": [\"35874803\", \"37036298\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Posttranscriptional mechanism stabilizing KCC3a protein unidentified\", \"Functional role in acid-base handling not directly tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended KCC3's renal role to basal NCC regulation in the distal convoluted tubule and identified an additional mislocalizing disease mutation linking KCC3 dysfunction to cellular senescence.\",\n      \"evidence\": \"DCT-specific conditional KO with NCC immunoblotting/RT-qPCR; patient-cell localization, ion measurement, and senescence marker analysis for p.H371R\",\n      \"pmids\": [\"40875335\", \"39988558\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which KCC3 controls NCC expression unknown\", \"Causal link between mislocalization and senescence not mechanistically established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how perinatal KCC3-dependent volume control becomes permanently fixed into irreversible axonal pathology, and what phosphatase/upstream signals reverse the WNK/SPAK inhibitory phosphorylation during swelling.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Activating phosphatase for Ser-96/Thr-991/Thr-1048 not identified\", \"Molecular basis of developmental irreversibility unknown\", \"No high-resolution structure of human KCC3\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 7, 17, 20]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 12, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 5, 7, 19, 22]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [13, 26]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 7, 17]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9, 11, 12, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"KCC2\", \"SPAK\", \"WNK3\", \"MO25\", \"SYK\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}